Compliance

The offer is a flat monthly fee, no site visits, and a business owned by someone without a license. Boards have a name for that arrangement, and it is not medical direction.

The RN injects. The RN does not evaluate. Every state that has written the rule down puts the exam with a physician, NP or PA, and puts it before the treatment.

Florida, Texas and California let a prescriber evaluate by video if the standard of care is met. Louisiana wants a physician on the premises. Mississippi does not count telemedicine hours at all.

Washington says yes, with a practitioner on the premises and no drug in the line. Texas says the person administering elective IV therapy is a PA, APRN or RN. California and Florida say no.

Louisiana lets an RN inject neurotoxin and bars the same RN from filler. Washington caps a physician at three PAs. Colorado lets unlicensed staff inject if you tell the patient.

Not for human consumption is doing enormous load-bearing work on peptide websites. The FDA has said in writing, repeatedly, that it does not control.

The supplement lane exists. Most peptides are not admitted to it, for structural reasons rather than enforcement priorities. Plus the branded path that is genuinely open.

Every telehealth TRT clinic prescribes testosterone under a temporary exception with an expiry date. The Ryan Haight in-person requirement was never repealed.

Blood leaves the patient, is handled, and goes back in through breached skin. The risk is not the product — it is contamination and chain of custody.

An AI scribe changes who writes the first draft. It does not change who owns the record, what it must contain, or how the data must be protected.

Approved, cleared, registered, compounded: four different things, routinely used interchangeably in aesthetics marketing. The distinctions determine what you may legally say.

Who is allowed to perform a good faith exam, the three moments that trigger a new one, how telehealth changes the answer, and what the documentation has to contain.